Work

283 Phase I Clinical Trial of M032, an IL-12 Expressing Oncolytic HSV-1, for Adult Patients With Recurrent Malignant Glioma

Year: 2025

Type: conference-abstract

Source: Neurosurgery

DOI: 10.1227/neu.0000000000003360_283

Authors: Dagoberto Estevez-Ordonez, John Stein, Pedram Malekenia, Carlos Gallegos, Travis Atchley, Nicholas M. Laskay, Jennifer Clements, Jianmei Leavenworth, Kristen O. Riley, Mina Lobbous, Inmaculada Aban, Ana Sorace, Burt Nabors, James M. Markert

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408448818

Cites:

Cited by:

Related to: 10